Company / Return on Assets (ROA)
Sonoma Pharmaceuticals, Inc. Return on Assets (ROA) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-35.3%
FY2025
5-year range
-35.3% / -21.0%
FY2021-FY2025
Trend
-1.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has declined for 3 consecutive years, from -21.0% in FY2022 to -35.3% in FY2025.
Based on SEC 10-K filings.
-35.3% in FY2025 with a 5-year CAGR of +45.7%.
Declined from -31.3% to -35.3% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -14.4pp
- 5-Year Change
- +45.7pp
- 10-Year Change
- -
Key checks
Key Insights
- Sonoma Pharmaceuticals, Inc.'s return on assets (roa) has declined for 3 consecutive years.
- In FY2025, return on assets (roa) decreased 1.0% year-over-year.
- Peak return on assets (roa) was recorded in FY2018.
- Lowest return on assets (roa) in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | -35.3% | -1.0% |
| FY2024 | -34.9% | -11.5% |
| FY2023 | -31.3% | -49.5% |
| FY2022 | -21.0% | +5.0% |
| FY2021 | -22.1% | +72.8% |
| FY2020 | -81.0% | +18.3% |
| FY2019 | -99.2% | -305.4% |
| FY2018 | 48.3% | +221.0% |
| FY2017 | -39.9% | +32.8% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026